Anti-Müllerian Hormone (AMH)FEMALE
A hormone produced by developing ovarian follicles — the best available marker of ovarian reserve (how many eggs remain).
The key fertility-planning marker for women, and also markedly elevated in PCOS. Unlike FSH, it can be drawn on any cycle day.
Check a Anti-Müllerian Hormone (AMH) result against this range →
What Anti-Müllerian Hormone (AMH) actually measures — the analyte, and the assay
The analyte is anti-Mullerian hormone, a disulfide-linked dimeric glycoprotein of the TGF-beta superfamily secreted by the granulosa cells of preantral and small antral follicles. It is made as a proprotein and cleaved into an N-terminal pro-region and a C-terminal mature dimer that stay non-covalently associated in circulation, so several molecular species of AMH are present at once and an assay's antibodies determine which of them it counts.
That is the root of this marker's whole measurement problem, and it is bigger than most people testing for ‘ovarian reserve’ realize. There are now 21 commercially available AMH immunoassay platforms or methods, and there is still no internationally agreed reference preparation to calibrate them against Li 2021. Automated random-access platforms are the more reliable of the group, but reliability within a method is not agreement between methods.
Here is that disagreement measured. A candidate international standard was assessed by five laboratories using seven immunoassay methods. The estimated AMH content of the same ampoule came out at a geometric mean of 361.76 ng with a geometric coefficient of variation of 39.95% across all assays — 26.67% when restricted to commercial ones — and across serum samples spanning 0.1 to 13.0 ng/mL the inter-method geometric CV ran 14.90% to 22.35% for samples above 0.3 ng/mL Ferguson 2018. Put plainly: the same serum, seven methods, and a spread of roughly a fifth of the value even in the well-behaved part of the range.
One number in that study deserves separating out: 0.3 ng/mL. The 14.90% to 22.35% inter-method spread was reported for samples above 0.3 ng/mL Ferguson 2018. Agreement at the very bottom of the range was not what those figures describe — and the bottom of the range is exactly where a woman is told she has diminished reserve. The measurement is least trustworthy at the concentration that changes the most decisions.
What to do with that as a patient. Two things, and both are concrete. Ask which platform ran it and keep using that one; and treat any AMH cut-off you read anywhere — in a clinic leaflet, in a study, on a forum — as belonging to the assay it was derived on until proven otherwise, because assay-to-assay and interval-to-interval differences are a recognized driver of endocrine misclassification Lorde 2023.
Anti-Müllerian Hormone (AMH): what changes the blood, and what only changes the reading
What changes the AMH in your blood:
- Age, and it dominates. AMH reflects the size of the growing follicle pool, which declines across reproductive life; this is the signal the test exists to carry and everything else is a modifier.
- Polycystic ovary syndrome. More small antral follicles means more granulosa cells secreting AMH, which is why AMH is high in PCOS and why it now stands in for ovarian morphology — the current diagnostic framework accepts polycystic ovarian morphology or an elevated AMH as one of the three features, two of which are needed Joham 2025 Piltonen 2024.
- Hormonal contraception, and it is not trivial. Combined contraceptives suppress the gonadotropin drive to the follicle pool and lower measured AMH; a result taken on the pill understates reserve and should be interpreted with that on the requisition.
- Ovarian surgery, chemotherapy and pelvic radiation, which remove or destroy follicles and lower AMH durably.
- Smoking, which accelerates follicular loss.
- Cycle day — hardly at all. This is the marker's genuine practical advantage over FSH: the growing follicle pool changes slowly, so AMH can be drawn on any day. That is a real property of the analyte, not a marketing claim.
What changes only the reading:
- Which of the 21 available methods ran it Li 2021 — the dominant analytical term, quantified above at an inter-method spread of 14.90% to 22.35% on real sera Ferguson 2018.
- Which assay generation. Manual plate assays and later automated platforms were calibrated differently, so a value from an older report is not comparable with a current one without knowing both.
- Sample handling and assay-specific interferences, which are part of why the field moved toward automated random-access platforms, reported as the more reliable of the methods compared Li 2021.
- The reference interval printed beside it, which is age-banded, assay-specific and not standardized between providers Piltonen 2024 Lorde 2023.
Reference interval or decision threshold — which kind of number Anti-Müllerian Hormone (AMH) is
This is the marker where the question in this section's title has a genuinely double answer, and saying so is the point. AMH is REPORTED as an age-banded reference interval and USED as a decision threshold, and the two roles are held to different standards of evidence.
As an interval, it is the central spread of whatever population that laboratory measured, on one of 21 methods, with no internationally agreed calibrator behind it Li 2021. Two laboratories therefore disagree by construction, and the measured inter-method spread is 14.90% to 22.35% Ferguson 2018 — enough to move a borderline result across a band boundary.
As a threshold, it does real work: fertility services use AMH cut-offs to anticipate poor and high response to ovarian stimulation, and a meta-analysis of 26 studies found AMH predicted poor response with a diagnostic odds ratio of 2.68 (95% CI 1.90 to 3.45) and high response at 2.76 (95% CI 1.57 to 3.95), with antral follicle count and AMH outperforming FSH and estradiol Salemi 2024. Two things deserve saying about those numbers. They are modest odds ratios, not the near-certainty the test is often sold with; and heterogeneity between studies was 95.65%, which is exactly what you would expect from pooling thresholds derived on assays that do not agree with each other.
And in PCOS the threshold is explicitly unresolved. AMH is a usable stand-in for polycystic ovarian morphology inside the diagnostic criteria Joham 2025, but there is no universal cut-off, and age- and assay-specific ranges remain to be established Piltonen 2024. A page that quotes a single number as ‘the PCOS level’ is quoting one laboratory's opinion.
How you would know your Anti-Müllerian Hormone (AMH) was wrong — and when to redraw
Not before six months, and usually not at all. AMH indexes the growing follicle pool, and that pool turns over across months rather than days — which is also why cycle day does not matter. A repeat at six weeks measures assay noise. A repeat at six to twelve months, on the SAME platform, measures something.
What has to be true for the second value to mean anything: the same method (an inter-method spread of up to 22.35% is larger than most of the change anyone is looking for Ferguson 2018), the same contraceptive status, and a stated age band, since the interval moves under you as you age.
What would have to change alongside it:
- LH/FSH drawn on days 2–5, because a genuinely falling reserve raises FSH as the follicle pool stops restraining it — AMH falling with FSH flat over a year is a weaker finding than the two moving together.
- Estradiol on the same early-follicular draw, without which an FSH cannot be interpreted.
- An antral follicle count by transvaginal ultrasound, which the pooled evidence puts alongside AMH as the better predictor of ovarian response Salemi 2024. This is the independent check: two methods, one biology.
- Total testosterone and cycle history where the elevated-AMH question is PCOS rather than reserve Joham 2025.
The falsifying pattern: an AMH that drops between two reports while the antral follicle count and FSH are unchanged, and the laboratory changed platform, is an assay change and not an ovarian one — check the method before booking anything.
What Anti-Müllerian Hormone (AMH) cannot tell you
It counts follicles, not eggs that will work. AMH is a quantity marker. It says nothing about oocyte quality, which is the variable that drives live birth and which tracks age independently.
It does not predict whether you will conceive naturally. The evidence behind AMH thresholds comes from predicting response to controlled ovarian stimulation, and even there the diagnostic odds ratios sit near 2.7 with extreme between-study heterogeneity Salemi 2024. Extrapolating a stimulation-response marker to spontaneous fertility is the commonest misuse of this test.
It cannot be compared between laboratories or between assay generations, because there is no agreed international standard and 21 methods are in circulation Li 2021 Ferguson 2018.
It cannot be read as an ovarian age in years. The pooled evidence behind AMH is prediction of ovarian response, at diagnostic odds ratios of 2.68 and 2.76 with 95.65% between-study heterogeneity Salemi 2024; no published model converts a concentration into a remaining number of fertile years.
A high value is not good news. In practice it most often reflects polycystic ovarian morphology, which is one of the diagnostic features of PCOS rather than a sign of superior fertility Joham 2025.
And a low value is not a deadline. The wrong inference readers draw — that a low AMH means the door is closing on a schedule the number can tell them — is not supported by what the marker measures or by how well it measures it. A low AMH is a reason to have a conversation with a reproductive endocrinologist, and to repeat it on the same platform before treating it as a fact.
Sources read for these sections
- Li HWR, et al. Challenges in Measuring AMH in the Clinical Setting. Frontiers in Endocrinology 2021 · PMID 34108942
- Ferguson JM, et al. Towards international standardization of immunoassays for Mullerian inhibiting substance/anti-Mullerian hormone. Reproductive BioMedicine Online 2018 · PMID 30241771
- Salemi F, et al. The best ovarian reserve marker to predict ovarian response following controlled ovarian hyperstimulation: a systematic review and meta-analysis. Systematic Reviews 2024 · PMID 39695880
- Piltonen TT, et al. Utility of Serum Anti-Mullerian Hormone Measurement as Part of Polycystic Ovary Syndrome Diagnosis. Seminars in Reproductive Medicine 2024 · PMID 38776986
- Joham AE, et al. Approach to the Patient: Diagnostic Challenges in the Work Up for Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism 2025 · PMID 39836632
- Lorde N, et al. Impact of Variation between Assays and Reference Intervals in the Diagnosis of Endocrine Disorders. Diagnostics (Basel) 2023 · PMID 37998589
The plan of attack
In this order. Most people start at step four, which is why they change five things at once and learn nothing.
- Confirm the number is real
Assay generation and lab. AMH assays have changed repeatedly and older and newer platforms do not agree. A 'fall' between tests can be a change of assay. Compare only within the same lab and assay. - Read it with its partner
Can be drawn any cycle day, unlike FSH/LH — one of its practical advantages. Draw it alongside: LH & FSH, Estradiol, Standard (ECLIA), Total Testosterone. - Work out which direction is yours
If it's high — Often reflects PCOS (many small follicles) rather than superior fertility.
If it's low — Diminished ovarian reserve — relevant to family planning timelines. It predicts egg quantity, not quality, and does not by itself predict natural conception. - Fix it in this order
Nutrition. Nothing reliably raises AMH. Overall nutritional status and healthy body composition support reproductive function.
Lifestyle. Stop smoking — it accelerates ovarian aging measurably. Maintain healthy body composition.
Supplements. CoQ10 and DHEA are used in fertility clinics for egg quality in some protocols — evidence is mixed and this belongs with a reproductive endocrinologist.
Hormones. Family-planning decisions (including egg freezing) belong with a reproductive endocrinologist. Hormonal contraception can modestly lower measured AMH.
Compounds. No peptide application. Purely informational.
Work down the list, not across it. Adding a compound on top of an unfixed diet is why generic protocols fail. - Retest
As guided by a fertility specialist. Change one thing at a time, or the retest can't tell you which thing worked.
How to fix it
📚 Practice Committee, Fertil Steril — AMH in ovarian reserve testing.
This page can tell you what could have made your Anti-Müllerian Hormone (AMH) wrong. It cannot tell you whether it did.
Everything above is free and stays free — the assay, what changes the reading rather than the blood, the retest window and the sources. What no page can do is look at your draw: which laboratory ran it, at what hour, what you were taking that week, and what else was flagged beside it. Every one of those changes the answer, and none of them is on any page. Bringing a real result to people who know that list is what the members' area is for.
Bring your result — $10/mo →🩸 Test your Anti-Müllerian Hormone (AMH)
Order directly through Marek Diagnostics — no doctor's visit needed, drawn at any Quest location in the US. Code CAMERON applies 10% off automatically.
Order this test — 10% off → Browse all 103 markers →What Anti-Müllerian Hormone (AMH) is usually tested alongside
One marker is a data point. These panels add the markers that make Anti-Müllerian Hormone (AMH) interpretable, name why each is on the list, and load the set into your cart at 10% off.
includes this + 9 more markers · built for women — Planning a pregnancy, actively trying, or wanting to understand your ovarian reserve before making decisions about timing.
What people use Anti-Müllerian Hormone (AMH) to decide
Nobody orders a test for its own sake. Anti-Müllerian Hormone (AMH) is on the test list for these pathways — each one links to what the pathway claims, and what its test list is read for before you spend anything on it.
A single draw can mislead badly here — perimenopausal estrogen swings wildly rather than declining smoothly, which is why women get told their labs are normal while feeling anything but. AMH gives the more stable signal.
The most complete workup on this page, and it earns it. Raised AMH with an LH:FSH ratio above 2 and low SHBG is the classic picture; 17-OH-progesterone is there to rule out congenital adrenal hyperplasia, which mimics PCOS and is treated completely differently.
Thyroid antibodies belong on this list even with a normal TSH — they independently raise miscarriage risk, and they are routinely left off fertility workups.
Would you feel it? Symptoms Anti-Müllerian Hormone (AMH) helps explain
People search for how they feel, not for a marker. These are the complaints where this one is worth checking, and whether it is first-line or a follow-up.
Why your Anti-Müllerian Hormone (AMH) might be wrong
Most abnormal results are interference, not disease. Check these before you change anything. Each says whether the number is wrong (repeat it), badly timed (redraw it), or real with a cause.
AMH assays have changed repeatedly and older and newer platforms do not agree. A 'fall' between tests can be a change of assay.
Compare only within the same lab and assay.
Lowers AMH by roughly 20–30% while you are on it, recovering after stopping.
A low AMH measured on the pill is not your true reserve.
AMH degrades with delayed processing and with repeated freeze-thaw cycles, both of which lower the reported value below your true reserve.
Use a lab that processes promptly, and stay with it for any repeat.
What Anti-Müllerian Hormone (AMH) means in combination
One marker tells you a little; combinations tell you the story. These are the named patterns this one takes part in.
Far less alarming than it feels. AMH describes egg quantity and predicts response to IVF stimulation well — it predicts natural conception poorly. Large cohort work found no association between low AMH and reduced chance of conceiving naturally within twelve months.
It matters for IVF planning, egg freezing and timing decisions. It does not tell a 32-year-old trying naturally whether this month will work. Read it with day-3 FSH and estradiol, not alone.
What to test next
These put Anti-Müllerian Hormone (AMH) in context — each with its own full breakdown.
Frequently asked questions
Age-dependent: ~1.0–4.0 ng/mL in the late 20s–early 30s, declining with age. <1.0 suggests diminished reserve; >4–5 ng/mL is common in PCOS. Ranges vary by laboratory and assay — always compare to the range printed on your own report.
Age-appropriate. This is an informational marker for planning — not something to 'optimize'.
Often reflects PCOS (many small follicles) rather than superior fertility.
Diminished ovarian reserve — relevant to family planning timelines. It predicts egg quantity, not quality, and does not by itself predict natural conception.
You can order Anti-Müllerian Hormone (AMH) directly through Marek Diagnostics without a doctor's visit — drawn at any Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically.
Where this goes next
This page is the free framework. The protocol itself — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.